{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:45:24Z","timestamp":1790383524430,"version":"4.1.0"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T00:00:00Z","timestamp":1585612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T00:00:00Z","timestamp":1585612800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Abbott Vascular Int."},{"name":"Amgen Cardiovascular"},{"name":"AstraZeneca"},{"name":"Bayer"},{"name":"Boehringer Ingelheim"},{"name":"Boston Scientific"},{"name":"The Bristol Myers Squibb and Pfizer Alliance"},{"name":"The Alliance Daiichi Sankyo Europe GmbH and Eli Lilly and Company"},{"DOI":"10.13039\/100006520","name":"Edwards","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006520","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Gedeon Richter Plc."},{"name":"Menarini Int. Op."},{"name":"MSD-Merck & Co."},{"name":"Novartis Pharma AG"},{"DOI":"10.13039\/100017647","name":"ResMed","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017647","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011725","name":"SERVIER","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Vifor"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,5,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>International guidelines recommend pharmacotherapy combinations for chronic coronary syndromes (CCSs) but medical management remains suboptimal.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>The CICD-LT registry is investigating short- and long-term outcomes and management in patients in European Society of Cardiology (ESC) member countries, in a longitudinal ESC EURObservational Research Programme aimed at improving CCS management.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Between 1 May 2015 and 31 July 2018, 9174 patients with previous ST-elevation myocardial infarction (STEMI), non-STEMI or coronary revascularisation, or other CCS, were recruited during a routine ambulatory visit or elective revascularisation procedure. Baseline clinical data were recorded and prescribed medications analysed at initial contact and discharge, and according to patient gender and age (&amp;lt;75 vs. \u226575 years).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Poorly controlled cardiovascular risk factors, including current smoking (18.5%), obesity (33.9%), diabetes (25.8%), raised low-density lipoprotein cholesterol (73.3%) and persistent hypertension (24.7%), were common across all cohorts. At ambulatory visit or admission, the guidelines-recommended combination of angiotensin-converting enzyme inhibitor\/angiotensin receptor blocker, beta-blocker, aspirin, statin and any antiplatelet agent was prescribed to 57.8% of patients with STEMI\/NSTEMI. Differences in prescribing rates, including for combination therapies, were observed based on age and gender and persisted after adjustment for demographic factors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Cardiovascular risk factors were common in contemporary CCS patients and secondary prevention prescribing was suboptimal. Patients aged \u226575 years and, to some extent, female patients were less likely to receive guidelines-recommended drug combinations than younger and male patients. One- and two-year follow-up will study prescribing changes and associations between baseline characteristics\/prescribing and subsequent clinical outcomes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1177\/2047487320912491","type":"journal-article","created":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T03:00:46Z","timestamp":1585623646000},"page":"432-445","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":20,"title":["Profile and treatment of chronic coronary syndromes in European Society of Cardiology member countries: The ESC EORP CICD-LT registry"],"prefix":"10.1093","volume":"28","author":[{"given":"Michel","family":"Komajda","sequence":"first","affiliation":[{"name":"Department of Cardiology Saint Joseph Hospital, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cosentino","sequence":"additional","affiliation":[{"name":"Unit of Cardiology, Karolinska Institutet and Karolinska University Hospital Solna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Ferrari","sequence":"additional","affiliation":[{"name":"Centro Cardiologico Universitario di Ferrara, University of Ferrara, Italy"},{"name":"Maria Cecilia Hospital, GVM Care & Research, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Kerneis","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, ACTION Study Group, INSERM UMRS1166, ICAN - Institute of CardioMetabolism and Nutrition Institut de Cardiologie, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re (AP-HP), France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Kosmachova","sequence":"additional","affiliation":[{"name":"Scientific Research Clinical hospital, # 1 Kuban State Medical University, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Laroche","sequence":"additional","affiliation":[{"name":"EURObservational Research Programme, ESC, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo P","family":"Maggioni","sequence":"additional","affiliation":[{"name":"Maria Cecilia Hospital, GVM Care & Research, Italy"},{"name":"EURObservational Research Programme, ESC, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Rittger","sequence":"additional","affiliation":[{"name":"Medizinische Klinik 1, Klinikum Fuerth, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe G","family":"Steg","sequence":"additional","affiliation":[{"name":"H\u00f4pital Bichat, Assistance Publique-H\u00f4pitaux de Paris, and Universit\u00e9 de Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Szwed","sequence":"additional","affiliation":[{"name":"2nd Department of Coronary Artery Disease Institute of Cardiology, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Tavazzi","sequence":"additional","affiliation":[{"name":"Maria Cecilia Hospital, GVM Care & Research, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Valgimigli","sequence":"additional","affiliation":[{"name":"Bern University Hospital, Inselspital, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris P","family":"Gale","sequence":"additional","affiliation":[{"name":"Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, UK"},{"name":"Leeds Institute for Data Analytics, University of Leeds, UK"},{"name":"Department of Cardiology, Leeds Teaching Hospitals NHS Trust, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the CICD investigators group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,3,31]]},"reference":[{"key":"2021070804575369300_zwaa288-B1","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1161\/CIRCULATIONAHA.114.008720","article-title":"Global and regional patterns in cardiovascular mortality from 1990 to 2013","volume":"132","author":"Roth","year":"2015","journal-title":"Circulation"},{"key":"2021070804575369300_zwaa288-B2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.gheart.2018.09.512","article-title":"The 2000\u20132016 Global Atlas of CVD","volume":"13","author":"Moran","year":"2018","journal-title":"Glob Heart"},{"key":"2021070804575369300_zwaa288-B3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.gheart.2018.09.511","article-title":"Global atlas of cardiovascular disease 2000-2016: The path to prevention and control","volume":"13","author":"Thomas","year":"2018","journal-title":"Glob Heart"},{"key":"2021070804575369300_zwaa288-B4","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/eurheartj\/ehx628","article-title":"European Society of Cardiology: Cardiovascular disease statistics 2017","volume":"39","author":"Timmis","year":"2018","journal-title":"Eur Heart J"},{"key":"2021070804575369300_zwaa288-B5","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2012.07.013","article-title":"Guidelines for the diagnosis and management of patients with stable ischemic heart disease: A report of the American College of Cardiology\/Foundation\/American Heart Association Task Force on Practice Guidelines and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons","volume":"60","author":"Fihn","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2021070804575369300_zwaa288-B6","author":"Knuuti","year":"2019"},{"key":"2021070804575369300_zwaa288-B7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/2047487317751955","article-title":"The chronic ischaemic cardiovascular disease ESC Pilot Registry: Results of the six-month follow-up","volume":"25","author":"Komajda","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"2021070804575369300_zwaa288-B8","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jama.295.2.180","article-title":"International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis","volume":"295","author":"Bhatt","year":"2006","journal-title":"JAMA"},{"key":"2021070804575369300_zwaa288-B9","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1177\/2047487318825350","article-title":"Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry","volume":"26","author":"Kotseva","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"2021070804575369300_zwaa288-B10","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/clc.22730","article-title":"Rationale, design, and baseline characteristics of the CLARIFY registry of outpatients with stable coronary artery disease","volume":"40","author":"Sorbets","year":"2017","journal-title":"Clin Cardiol"},{"key":"2021070804575369300_zwaa288-B11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/eurheartj\/ehv437","article-title":"EURObservational Research Programme: The Chronic Ischaemic Cardiovascular Disease Registry: Pilot phase (CICD\u2013PILOT","volume":"37","author":"Komajda","year":"2016","journal-title":"Eur Heart J"},{"key":"2021070804575369300_zwaa288-B12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.clinthera.2018.11.012","article-title":"Post-myocardial Infarction (MI) care: Medication adherence for secondary prevention after MI in a large real-world population","volume":"41","author":"Huber","year":"2019","journal-title":"Clin Ther"},{"key":"2021070804575369300_zwaa288-B13","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1093\/eurheartj\/ehu078","article-title":"Renin\u2013angiotensin system antagonists and clinical outcomes in stable coronary artery disease without heart failure","volume":"35","author":"Sorbets","year":"2014","journal-title":"Eur Heart J"},{"key":"2021070804575369300_zwaa288-B14","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/jama.2012.12559","article-title":"B-blocker use and clinical outcomes in stable outpatients with and without coronary artery disease","volume":"308","author":"Bangalore","year":"2012","journal-title":"JAMA"},{"key":"2021070804575369300_zwaa288-B15","author":"Sorbets","year":"2018"},{"key":"2021070804575369300_zwaa288-B16","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0140-6736(18)31924-X","article-title":"Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): A randomised, double blind, placebo-controlled trial","volume":"392","author":"Gaziano","year":"2018","journal-title":"Lancet"},{"key":"2021070804575369300_zwaa288-B17","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa1804988","article-title":"Effects of aspirin for primary prevention in persons with diabetes mellitus","volume":"379","author":"Bowman","year":"2018","journal-title":"N Engl J Med"},{"key":"2021070804575369300_zwaa288-B18","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJMoa1803955","article-title":"Effect of aspirin on all-cause mortality in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N Engl J Med"}],"updated-by":[{"DOI":"10.1177\/2047487320924592","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T00:00:00Z","timestamp":1588118400000}}],"container-title":["European Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2047487320912491","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2047487320912491","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/eurjpc\/article-pdf\/28\/4\/432\/37900342\/zwaa288.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/eurjpc\/article-pdf\/28\/4\/432\/37900342\/zwaa288.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T04:59:37Z","timestamp":1625720377000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/article\/28\/4\/432\/6272726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,31]]},"references-count":18,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,3,31]]},"published-print":{"date-parts":[[2021,5,8]]}},"URL":"https:\/\/doi.org\/10.1177\/2047487320912491","relation":{"correction":[{"id-type":"doi","id":"10.1177\/2047487320924592","asserted-by":"object"}]},"ISSN":["2047-4873","2047-4881"],"issn-type":[{"value":"2047-4873","type":"print"},{"value":"2047-4881","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4,1]]},"published":{"date-parts":[[2020,3,31]]}}}